HPAPI and cytotoxic drugs contract manufacturing market is projected to reach USD 25 billion by 2030

Development initiatives of HPAPIs and cytotoxic drugs are generally very demanding, both in terms of experience and capital investment. Most companies generally lack the necessary resources to meet the aforementioned requirements and are unable to set up dedicated HPAPI and cytotoxic drug manufacturing facilities. This has led to an increased demand for contract manufacturing service providers in this field.
The USD 25 billion (by 2030) financial opportunity within the HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020- 2030 has been analyzed across the following segments:
Type of Product
  • HPAPIs
  • Highly Potent Finished Dosage Forms
Company Size
  • Small-sized
  • Mid-sized
  • Large / Very Large
Scale of Operation
  • Preclinical / Clinical
  • Commercial
Type of Pharmacological Molecule
  • Small Molecules
  • Biologics
Type of Highly Potent Finished Dosage Form
  • Injectables
  • Oral Solids
  • Creams
  • Others
Key geographical regions
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World
For more information, please visit https://www.rootsanalysis.com/reports/299/request-sample.html
The “HPAPI and Cytotoxic Drugs Manufacturing (3rd Edition) 2020-2030” report features the following companies, which we identified to be key players in this domain:  
  • AbbVie Contract Manufacturing
  • CARBOGEN AMCIS
  • Catalent
  • Evonik
  • Formosa Laboratories
  • Intas
  • Lonza
  • MabPlex
  • Pfizer CentreOne
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Competitive Analysis
6. HPAPI and Cytotoxic Drugs Contract Manufacturers based in North America: Company Profiles
7. HPAPI and Cytotoxic Drugs Contract Manufacturers based in Europe: Company Profiles
8. HPAPI and Cytotoxic Drugs Contract Manufacturers based in Asia Pacific: Company Profiles
9. Partnerships and Collaborations
10. Recent Expansions
11. Capacity Analysis
12. Market Sizing and Opportunity Analysis
13. Case-In-Point: Contract Manufacturing of Antibody Drug Conjugates
14. Concluding Remarks
15. Executive Insights
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
Get Customized Report:
https://www.rootsanalysis.com/reports/299/request-customization.html    
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com

0 Comments Write your comment

    1. Loading...